The renin-angiotensin system (RAS) has been identified as a potential pharmacotherapeutic target for PTSD as retrospective clinical studies have shown that treatment with angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) are associated with fewer PTSD symptoms1,2. Here, ACE is linked to post-traumatic stress disorder.